PainTEQ Announces Appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
dysfunction, today announced the appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research, effective immediately. In this role, Dr. Venkatesan will lead PainTEQ's clinical research strategy, overseeing evidence generation, scientific communications, and clinical development initiatives to support the company's growing portfolio of minimally invasive SI joint technologies. "PainTEQ has a unique opportunity to help redefine how SI joint dysfunction is studied and treated," said Dr. Venkatesan. "I am excited to join the team and focus on building a strong, transparent clinical evidence foundation that supports physicians in delivering meaningful outcomes for their patients." Dr. Venkatesan brings more than a decade of experience in neuromodulation and medical device innovation, with deep expertise in clinical strategy, scientific engagement, and evidence dissemination. Most recently, he served as Senior Director of Global Medical Affairs at Saluda Medical, w
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Innovative Health Receives 50th FDA Clearance to Reprocess Medical Devices [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 80% of the company [Yahoo! Finance]Yahoo! Finance
- Can your toothbrush really detect diabetes? FDA scrutiny grows for health-tracking gadgets [Los Angeles Times (CA)]Los Angeles Times
- Global Pain Management Devices Market to Reach USD 5,835.8 Million by 2029 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at Sanford C. Bernstein from $150.00 to $154.00. They now have an "outperform" rating on the stock.MarketBeat
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- ABT's page on the SEC website